Finabase

    • Login
    • Categories
    Home Watchlists Portfolios Map Forex Futures Crypto Comparisons Alerts Screeners Backtests vTrading Settings Forum
    1. Home
    2. CAPR
    • Alert
    • Note
    CAPR
    Capricor Therapeutics, Inc.
    4.16
    -
    0.04
    0.95%
    10 x 4.05
    30 x 4.44
    bid
    ask
    20 @ 04:00 PM
    4.30+0.14 (3.37%)
    Bearish 26
    Bullish 88
    sentiment
    4.11
    day range
    4.30
    2.89
    52 week range
    6.55
    04:00 PM
    V: 59.97K
    C: 4.16
    L: 4.11
    H: 4.30
    O: 4.17
    loading chart ...
    • 1d
    • 5d
    • 1m
    • 3m
    • 6m
    • ytd
    • 1y
    • 2y
    • 5y
    • max
    • PDF
    • Full Chart
    • Stats
    • Watchlist
    • Portfolio
    Prev Close4.20
    Open4.17
    Low4.11
    High4.30
    Volume59.97K
    Avg. Volume122.05K
    Market Cap105.00M
    Inst. Own11.14%
    Beta4.17
    Short Ratio3.66
    Div & Yield0.00 /
    EPS-0.96
    P/E
    1yr Target15.00
    50day MA4.03
    200day MA4.51
    ^DJI
    Dow Jones Industrial Average
    33926.00
    04:54 PM
    -
    127.90
    0.38%
    ^IXIC
    NASDAQ Composite
    12007.00
    05:15 PM
    -
    193.80
    1.59%
    ^GSPC
    S&P 500
    4136.48
    04:54 PM
    -
    43.28
    1.04%
    AAPL
    154.40
    -0.10 (0.06%)
    Apple Inc.
    154.50
    17 @ 04:00 PM
    11 x 154.32
    22 x 154.43
    +
    3.68
    2.44%
    GOOG
    105.21
    -0.01 (0.01%)
    Alphabet Inc.
    105.22
    10 @ 04:00 PM
    11 x 105.06
    8 x 105.26
    -
    3.58
    3.29%
    AMZN
    102.93
    -0.46 (0.44%)
    Amazon.com, Inc.
    103.39
    11 @ 04:00 PM
    12 x 102.95
    10 x 102.91
    -
    9.52
    8.43%
    MSFT
    258.20
    -0.15 (0.06%)
    Microsoft Corporation
    258.35
    12 @ 04:00 PM
    13 x 258.00
    10 x 258.09
    -
    6.25
    2.36%
    BABA
    106.40
    +0.07 (0.07%)
    Alibaba Group Holding Limited
    106.33
    10 @ 04:01 PM
    11 x 0.00
    8 x 0.00
    -
    3.41
    3.11%
    NFLX
    365.90
    +0.00 (0.00%)
    Netflix, Inc.
    365.90
    9 @ 04:00 PM
    10 x 365.60
    8 x 365.90
    -
    0.99
    0.27%
    TSLA
    192.72
    +2.74 (1.44%)
    Tesla, Inc.
    189.98
    10 @ 04:00 PM
    11 x 192.72
    8 x 192.77
    +
    1.71
    0.91%
    NVDA
    210.75
    -0.25 (0.12%)
    NVIDIA Corporation
    211.00
    10 @ 04:00 PM
    9 x 210.76
    10 x 211.00
    -
    6.09
    2.81%
    AMD
    85.98
    -0.11 (0.13%)
    Advanced Micro Devices, Inc.
    86.09
    9 @ 04:00 PM
    10 x 85.98
    8 x 85.95
    -
    2.22
    2.51%
    MU
    62.29
    -0.12 (0.19%)
    Micron Technology, Inc.
    62.41
    12 @ 04:00 PM
    12 x 62.20
    12 x 62.50
    -
    0.76
    1.20%
    SPY
    411.63
    -0.72 (0.17%)
    SPDR S&P 500 ETF Trust
    412.35
    11 @ 04:00 PM
    9 x 411.38
    12 x 411.69
    -
    4.43
    1.06%
    TQQQ
    25.39
    -0.13 (0.51%)
    ProShares UltraPro QQQ
    25.52
    12 @ 04:00 PM
    12 x 25.39
    12 x 25.45
    -
    1.39
    5.17%
    BRK-A
    466755.00
    +0.00 (0.00%)
    Berkshire Hathaway Inc.
    466755.00
    10 @ 04:02 PM
    12 x 0.00
    8 x 0.00
    -
    5360.00
    1.14%
    Day Gain
    Gain
    Market Val
    Costs
    Cash
    Portfolio
    Realized
    Dividend
    • Summary
    • Discussion
    • News
    • Signals
    • Financials
    • Alerts
    • Notes
    • Chart
    • Backtest
    News ...
    2023-02-01 | CSE:CAPR | Press Release | Caprock Mining Corp. news.google.com •
    Caprock Announces Option to Acquire Ackley Li-Sn-Mo-REE Property in Newfoundland news.google.com •
    Capricor Therapeutics, Inc. (CAPR) Stock Price Today, Quote & News news.google.com •
    Capricor (CAPR) Upgraded to Buy: What Does It Mean for the Stock? zacks.com •
    Capricor Therapeutics, Inc. (CAPR) Q3 2022 Earnings Call Transcript seekingalpha.com •
    Capricor Therapeutics (CAPR) Reports Q3 Loss, Tops Revenue Estimates zacks.com •
    Profile ...
    Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.
    Earning ...
    Date For Estimate Reported Surprise surprise %
    2023-03-09 2022-12 -0.33 N/A N/A N/A
    2022-11-10 2022-09 -0.28 -0.26 0.02 7.14%
    2022-08-10 2022-06 -0.25 -0.29 -0.04 -16.00%
    2022-05-10 2022-03 0 -0.32 N/A N/A
    2022-03-10 2021-12 -0.19 -0.26 -0.07 -36.84%
    2021-11-09 2021-09 -0.22 -0.17 0.05 22.73%
    Upgrade / Downgrade ...
    Date Firm Action From To
    2022-10-26 Ladenburg Thalmann Upgrade Buy
    2022-01-31 HC Wainwright & Co. Upgrade Buy
    2021-10-11 HC Wainwright & Co. Upgrade Buy
    2020-11-25 H.C. Wainwright Upgrade Buy
    2020-11-25 H.C. Wainwright Upgrade Buy Buy
    2020-11-25 Maxim Group Upgrade Buy
    Insider Holder ...
    Date Name Relation Quantity Description
    2022-07-05 AVAT XAVIER Officer 3.00K Purchase
    2022-03-07 COLLIER EARL M JR Director 15.46K Conversion of Exercise of derivative security
    2022-03-28 DUNBAR GEORGE W JR Director 9.15K Conversion of Exercise of derivative security
    2017-12-26 KAZAM JOSHUA A Director 34.88K Stock Gift
    2022-11-02 KRASNEY KAREN General Counsel 20.05K Conversion of Exercise of derivative security
    2022-01-02 LITVACK FRANK I Director 107.38K Conversion of Exercise of derivative security
    Institution Ownership ...
    Report Date Organization Position Value Percentage
    2022-09-29 Vanguard Group, Inc. (The) 1.17M 4.88M 4.64%
    2022-09-29 Blackrock Inc. 437.23K 1.82M 1.73%
    2022-09-29 Geode Capital Management, LLC 222.03K 923.66K 0.88%
    2022-09-29 Dimensional Fund Advisors LP 163.12K 678.58K 0.65%
    2022-09-29 Susquehanna International Group, LLP 145.43K 604.99K 0.58%
    2022-09-29 Northern Trust Corporation 105.31K 438.07K 0.42%
    Fund Ownership ...
    Report Date Organization Position Value Percentage
    2022-09-29 Vanguard Total Stock Market Index Fund 767.24K 3.19M 3.04%
    2022-09-29 Vanguard Extended Market Index Fund 339.90K 1.41M 1.35%
    2022-12-30 iShares Core S&P Total U.S. Stock Market ETF 138.41K 575.80K 0.55%
    2022-11-29 Fidelity Extended Market Index Fund 116.50K 484.64K 0.46%
    2022-10-30 DFA U.S. Small Cap Series 76.21K 317.02K 0.30%
    2022-12-30 iShares Micro Cap ETF 47.12K 196.04K 0.19%
    Split ...
    Split Date
    1 : 10 2019-06-05
    1 : 50 2013-11-21
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • info 12
      info 12 last edited by

      $CAPR 👏👏👏👏👏👏👏👏👏👏👏

      1 Reply Last reply Reply Quote 0
      • info 12
        info 12 last edited by

        $CAPR 🏆🏆🏆🏆🏆

        1 Reply Last reply Reply Quote 0
        • info 12
          info 12 last edited by

          $CAPR hello $6.00

          1 Reply Last reply Reply Quote 0
          • info 12
            info 12 last edited by

            $CAPR $9.00 - $13.00 +++ 4th QTR ✅✅✅

            1 Reply Last reply Reply Quote 0
            • info 12
              info 12 last edited by

              $CAPR ⭐️⭐️⭐️⭐️⭐️

              1 Reply Last reply Reply Quote 0
              • info 12
                info 12 last edited by

                $CAPR slow is the fastest way to get there “Let’s Go” ⭐️⭐️⭐️⭐️⭐️

                1 Reply Last reply Reply Quote 0
                • info 12
                  info 12 last edited by

                  $CAPR ⭐️⭐️⭐️⭐️⭐️ let’s go everything is all set

                  1 Reply Last reply Reply Quote 0
                  • info 12
                    info 12 last edited by

                    $CAPR - no matter what no chance it’s going out of business and yeah stock price sucks now but like all the others it will climb back to $10,$20 plus ( just have to wait ) ⭐️⭐️⭐️⭐️⭐️

                    1 Reply Last reply Reply Quote 0
                    • info 12
                      info 12 last edited by

                      CAPR 5 Star hold for the win ⭐️⭐️⭐️⭐️⭐️

                      1 Reply Last reply Reply Quote 0
                      • info 12
                        info 12 last edited by

                        $CAPR $2,875.00 stock price Sep 30, 2007 “Just Say’n” Upon good news this will go way, way up 🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔🤔

                        1 Reply Last reply Reply Quote 0
                        • info 12
                          info 12 last edited by

                          $CAPR 🚂🚂🚂🚂🚂🚂🚂 waiting for this to run like a non stop locomotive, it’s coming soon!

                          1 Reply Last reply Reply Quote 0
                          • info 12
                            info 12 last edited by

                            $CAPR $120.00 price target 🎯

                            1 Reply Last reply Reply Quote 0
                            • info 12
                              info 12 last edited by

                              $CAPR looking 👀good ⭐️⭐️⭐️⭐️⭐️

                              1 Reply Last reply Reply Quote 0
                              • info 12
                                info 12 last edited by

                                $CAPR holding long for the win 🏅🏅🏅🏅🏅

                                1 Reply Last reply Reply Quote 0
                                • info 12
                                  info 12 last edited by

                                  $CAPR ⭐️⭐️⭐️⭐️⭐️ 5 star hold be patient while riding out the storm 😊

                                  1 Reply Last reply Reply Quote 0
                                  • info 12
                                    info 12 last edited by

                                    $CAPR ✅✅✅✅✅

                                    1 Reply Last reply Reply Quote 0
                                    • info 12
                                      info 12 last edited by

                                      $CAPR everything 👀 good

                                      1 Reply Last reply Reply Quote 0
                                      • info 12
                                        info 12 last edited by

                                        $CAPR ✅✅✅✅✅

                                        1 Reply Last reply Reply Quote 0
                                        • info 12
                                          info 12 last edited by

                                          $CAPR it’s only going higher ⭐️⭐️⭐️⭐️⭐️

                                          1 Reply Last reply Reply Quote 0
                                          • 1
                                          • 2
                                          • 3
                                          • 4
                                          • 5
                                          • 13
                                          • 14
                                          • 1 / 14
                                          • First post
                                            Last post
                                          • 2023-02-01 | CSE:CAPR | Press Release | Caprock Mining Corp.
                                            news.google.com •

                                          • Caprock Announces Option to Acquire Ackley Li-Sn-Mo-REE Property in Newfoundland
                                            news.google.com •

                                          • Capricor Therapeutics, Inc. (CAPR) Stock Price Today, Quote & News
                                            news.google.com •

                                          • Capricor (CAPR) Upgraded to Buy: What Does It Mean for the Stock?
                                            zacks.com •

                                          • Capricor Therapeutics, Inc. (CAPR) Q3 2022 Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Therapeutics (CAPR) Reports Q3 Loss, Tops Revenue Estimates
                                            zacks.com •

                                          • Capricor Therapeutics to Present Third Quarter 2022 Financial Results and Recent Corporate Update on November 10
                                            globenewswire.com •

                                          • Capricor Therapeutics to Present One-Year Results from HOPE-2 Open Label Extension Study at World Muscle Society 2022
                                            globenewswire.com •

                                          • Capricor Therapeutics to Present at Upcoming Investor Conferences
                                            globenewswire.com •

                                          • Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2022 Results Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Therapeutics to Present Second Quarter 2022 Financial Results and Recent Corporate Update on August 10
                                            globenewswire.com •

                                          • Capricor Therapeutics to Present One-Year Efficacy Results from its Ongoing HOPE-2 Open Label Extension Study at 2022 Parent Project Muscular Dystrophy Annual Conference
                                            globenewswire.com •

                                          • Capricor Therapeutics to Present at the H.C. Wainwright Global Investment Conference
                                            globenewswire.com •

                                          • Capricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q1 2022 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Therapeutics to Present First Quarter 2022 Financial Results and Recent Corporate Update on May 10
                                            globenewswire.com •

                                          • 7 Undervalued Penny Stocks With Major Upside
                                            investorplace.com •

                                          • Capricor Shares Fall After Topline Results From Mid-Stage COVID-19 Trial
                                            benzinga.com •

                                          • Capricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q4 2021 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Therapeutics to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on March 10
                                            globenewswire.com •

                                          • Capricor Therapeutics, Nippon Shinyaku Ink US Pact For Duchenne Muscular Dystrophy Candidate
                                            benzinga.com •

                                          • Forget Bargains, Play 5 Stocks With Rising P/E Instead
                                            zacks.com •

                                          • Here's Why Capricor (CAPR) is Poised for a Turnaround After Losing 19.3% in 4 Weeks
                                            zacks.com •

                                          • Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q3 2021 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Stock Is Moving Higher As Duchenne Dystrophy Cell Therapy Slows Disease Progression By 71%
                                            benzinga.com •

                                          • CAPR Stock: Why It Substantially Increased Today
                                            pulse2.com •

                                          • Capricor Therapeutics Announces Positive Final Data From its Phase 2 HOPE-2 Trial in Patients with Duchenne Muscular Dystrophy Treated with CAP-1002
                                            globenewswire.com •

                                          • Capricor Therapeutics to Present at the Upcoming Investor and Industry Healthcare Conferences
                                            globenewswire.com •

                                          • Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts
                                            pennystocks.com •

                                          • Capricor Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
                                            globenewswire.com •

                                          • Capricor Therapeutics to Present Final Data from HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at World Muscle Society 2021
                                            globenewswire.com •

                                          • Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2021 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Therapeutics to Present Second Quarter 2021 Financial Results and Recent Corporate Update on August 12
                                            globenewswire.com •

                                          • Strength Seen in Capricor (CAPR): Can Its 5.7% Jump Turn into More Strength?
                                            zacks.com •

                                          • Capricor Therapeutics to Participate in BIO Digital 2021 Conference
                                            globenewswire.com •

                                          • Capricor To Present Preclinical Data for Exosome-mRNA Vaccine for SARS-CoV-2 at the International Society for Extracellular Vesicles (ISEV) Annual Meeting
                                            globenewswire.com •

                                          • Capricor Therapeutics, Inc.'s (CAPR) CEO Linda Marbán on Q1 2021 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Therapeutics to Present First Quarter 2021 Financial Results and Recent Corporate Update on May 13
                                            globenewswire.com •

                                          • Capricor Therapeutics Stock Jumps On Engineered Exosomes Development Pact
                                            benzinga.com •

                                          • CAPR Stock: From $3.95 To Over $4.20 Pre-Market Explanation
                                            pulse2.com •

                                          • Capricor Therapeutics' (CAPR) CEO Linda Marbán on Q4 2020 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
                                            globenewswire.com •

                                          • Capricor Therapeutics - Shockingly Undervalued With Imminent Catalysts In Play
                                            seekingalpha.com •

                                          • Capricor Therapeutics Announces Development of Serology Test to Confirm Activity of SARS-CoV-2 Vaccines
                                            globenewswire.com •

                                          • Capricor Therapeutics Announces Publication Demonstrating Methods for Enhanced Potency of Cardiosphere-Derived Exosomes
                                            globenewswire.com •

                                          • Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
                                            globenewswire.com •

                                          • Capricor Therapeutics Announces DSMB Recommendation to Continue Phase II INSPIRE Trial for Severe COVID-19 Patients
                                            globenewswire.com •

                                          • Capricor Therapeutics, Inc's (CAPR) CEO Linda Marbán on Q3 2020 Results - Earnings Call Transcript
                                            seekingalpha.com •

                                          • Capricor Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
                                            globenewswire.com •

                                          • Capricor Therapeutics Announces Positive Preclinical Data for Multivalent Exosome-mRNA Vaccine For COVID-19
                                            globenewswire.com •

                                          • Capricor Therapeutics to Present Third Quarter 2020 Financial Results and Recent Corporate Update on November 12
                                            globenewswire.com •

                                          • Capricor Therapeutics (CAPR) Investor Presentation - Slideshow
                                            seekingalpha.com •

                                          • Capricor Therapeutics (NASDAQ:CAPR) Coverage Initiated by Analysts at Maxim Group
                                            thelincolnianonline.com •

                                          • The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
                                            benzinga.com •

                                          • Capricor Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
                                            finance.yahoo.com •

                                          • Capricor Therapeutics to Present Second Quarter 2020 Financial Results and Recent Corporate Update on August 6
                                            finance.yahoo.com •

                                          • The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
                                            benzinga.com •

                                          • Capricor Therapeutics (CAPR) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
                                            finance.yahoo.com •

                                          • Capricor Therapeutics (NASDAQ:CAPR) Is In A Good Position To Deliver On Growth Plans
                                            finance.yahoo.com •

                                          • ThermoGenesis Holdings: Many Short-Term Catalysts In Low-Float Stock
                                            seekingalpha.com •

                                          • Dyne Therapeutics Announces Appointment of Leading DMD Expert Francesco Muntoni to Scientific Advisory Board
                                            businesswire.com •

                                          • Global Duchenne Muscular Dystrophy Market (2020 to 2024) - Develop In-depth Knowledge of Competition and Markets - ResearchAndMarkets.com
                                            businesswire.com •

                                          • Capricor to Participate in BIO Digital International Convention
                                            finance.yahoo.com •

                                          • Here is What Hedge Funds Think About Capricor Therapeutics, Inc. (CAPR)
                                            finance.yahoo.com •

                                          • Capricor to Participate in Maxim Group's COVID-19 Virtual Conference Series on May 27, 2020
                                            finance.yahoo.com •

                                          • Pluristem Therapeutics: The Search For An ARDS Treatment, And Whether Its Growth Will Continue (NASDAQ:PSTI)
                                            seekingalpha.com •

                                          • Moderna y Sorrento se disparan en Bolsa por sus avances en el desarrollo de una cura
                                            cincodias.elpais.com •

                                          • Capricor Therapeutics (CAPR) Reports Q1 Loss, Lags Revenue Estimates
                                            finance.yahoo.com •

                                          • Capricor Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
                                            finance.yahoo.com •

                                          • Capricor Therapeutics to Present First Quarter 2020 Financial Results and Recent Corporate Update on May 14
                                            finance.yahoo.com •

                                          • Capricor Announces Positive Top-Line Final Results from HOPE-2 Study in Patients with Duchenne Muscular Dystrophy Treated with Lead Candidate CAP-1002
                                            finance.yahoo.com •

                                          • 6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
                                            investing.com •

                                          • 5 Stem Cell Companies Racing Towards COVID-19 ARDS Therapy
                                            seekingalpha.com •

                                          • Capricor (CAPR) Shares Could Hit $10, Says Analyst
                                            finance.yahoo.com •

                                          • Cómo hacerse millonario con una presunta cura en una sola sesión de Wall Street
                                            cincodias.elpais.com •

                                          • RDS.A, LYG among premarket losers
                                            seekingalpha.com •

                                          • Benzinga Pro's Top 5 Stocks To Watch For Thurs., Apr. 30, 2020: AAPL, LVS, MRNA, IMKTA, CAPR
                                            finance.yahoo.com •

                                          • The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
                                            finance.yahoo.com •

                                          • 108 Biggest Movers From Yesterday
                                            benzinga.com •

                                          • U.S. RESEARCH ROUNDUP- Labcorp, ServiceNow, Zebra Technologies
                                            reuters.com •

                                          • Capricor Therapeutics Shares Soar 250% On Successful COVID-19 Treatment News
                                            finance.yahoo.com •

                                          • The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
                                            benzinga.com •

                                          • Wednesday's Stock Market Close: US Equities Rise On Potential Virus Treatment, Fed Pledge To Keep Rates Near Zero
                                            ibtimes.com •

                                          • Mid-Afternoon Market Update: Dow Surges 600 Points; RR Donnelley & Sons Shares Spike Higher
                                            benzinga.com •

                                          • 82 Stocks Moving In Wednesday's Mid-Day Session
                                            benzinga.com •

                                          • Mid-Day Market Update: Crude Oil Jumps 32%; Fresh Del Monte Produce Shares Plummet After Q1 Results
                                            benzinga.com •

                                          • Mid-Morning Market Update: Markets Open Higher; General Electric Earnings Miss Views
                                            benzinga.com •

                                          • New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002
                                            finance.yahoo.com •

                                          • U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.21%
                                            investing.com •

                                          • Did You Manage To Avoid Capricor Therapeutics' (NASDAQ:CAPR) 97% Share Price Wipe Out?
                                            finance.yahoo.com •

                                          • Capricor Therapeutics to Host Key Opinion Leader Call on Cardiac Complications of Duchenne Muscular Dystrophy
                                            finance.yahoo.com •

                                          • 15 Healthcare Stocks Moving In Tuesday's Pre-Market Session
                                            benzinga.com •

                                          • This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside
                                            finance.yahoo.com •

                                          • Wall Street Analysts Are Bullish on Top Healthcare Picks
                                            smarteranalyst.com •

                                          • Wall Street Analysts Are Bullish on Top Healthcare Picks
                                            markets.co •

                                          • TSLA, ET among premarket gainers
                                            seekingalpha.com •

                                          • Shipping begins for Aytu rapid blood test - COVID-19 updates
                                            seekingalpha.com •

                                          • Capricor Initiates Compassionate Use Program for Severe COVID-19 Patients using CAP-1002, its Novel Cell Therapy
                                            finance.yahoo.com •

                                          • Analysts' Opinions Are Mixed on These Healthcare Stocks: Abeona Therapeutics (ABEO), Teva Pharmaceutical Industries (TEVA) and Capricor Therapeutics (CAPR)
                                            smarteranalyst.com •

                                          • Analysts’ Opinions Are Mixed on These Healthcare Stocks: Abeona Therapeutics (NASDAQ: ABEO), Teva Pharmaceutical Industries (NYSE: TEVA) and Capricor Therapeutics (NASDAQ: CAPR)
                                            analystratings.com •

                                          • CCL, RBS among premarket losers
                                            seekingalpha.com •

                                          Copyright © 2022 finabase.io